Reprinted with permission from Orthomolecular Medicine News Service
(OMNS Apr 14, 2011) Scientists have long studied the effects of mega-doses of vitamin C to treat a wide variety of illnesses and diseases. Research documents vitamin C as one of the best antiviral agents available. Vitamin C has been shown to neutralize and eliminate a wide range of toxins, and to enhance host resistance, greatly augmenting the immune system's ability to neutralize bacterial and fungal infections. Most importantly, there is extensive published research demonstrating vitamin C's anti-cancer properties. (1)
In the 1970s, Hugh D. Riordan, M.D. and colleagues began studying the underlying causes of cancer and ways to treat cancer in a non-toxic fashion. From this research came the Riordan Intravenous Vitamin C Protocol for Cancer. (2) This protocol is widely recognized in the integrative and orthomolecular medicine community and is commonly used as an effective adjunct to conventional oncologic therapy.
Oncologist Victor Marcial, M.D., has experience using it. He says: "We studied patients with advanced cancer (stage 4). 40 patients received 40,000-75,000 mg intravenously several times a week. . . In addition, they received a diet and other supplements. The initial tumor response rate was achieved in 75% of patients, defined as a 50% reduction or more in tumor size. . . As a radiation oncologist, I also give radiation therapy. Vitamin C has two effects. It increases the beneficial effects of radiation and chemotherapy and decreases the adverse effects. But this is not a subtle effect, is not 15-20%, it's a dramatic effect. Once you start using IV vitamin C, the effect is so dramatic that it is difficult to go back to not using it." (3)
In 2009 and 2010, Riordan IV-C and Cancer Symposiums brought together medical professionals, researchers and IV-C practitioners from the United States and abroad. The latest advancements in intravenous vitamin C cancer therapy were presented in detail and recorded on video.
OMNS readers are urged to have their physicians (especially oncologists) watch these important presentations.
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Ian Brighthope, M.D. (Australia)
Ralph K. Campbell, M.D. (USA)
Carolyn Dean, M.D., N.D. (Canada)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Michael Gonzalez, D.Sc., Ph.D. (Puerto Rico)
Steve Hickey, Ph.D. (United Kingdom)
James A. Jackson, Ph.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Thomas Levy, M.D., J.D. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Erik Paterson, M.D. (Canada)
W. Todd Penberthy, Ph.D. (USA)
Gert E. Shuitemaker, Ph.D. (Netherlands)
Jagan Nathan Vamanan, M.D. (India)
Andrew W. Saul, Ph.D., Editor and contact person. Email: [email protected]
To Subscribe at no charge: http://www.orthomolecular.org/subscribe.html.
The above provides a general overview on this topic and may not apply to everyone. Any treatment protocol should be discussed with a qualified healthcare practitioner ... Please refer to: Medical & Legal Disclaimer.